GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7CZY | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7D03 | P0DTC2 | S protein of SARS-CoV-2 in complex bound with FabP5A-2G7 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7DMU | P0DTC2 | Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 | |
7DWX | P0DTC2 | Conformation 1 of S-ACE2-B0AT1 ternary complex | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7DWY | P0DTC2 | S protein of SARS-CoV-2 in the locked conformation | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7E3K | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7EDG | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2 | |
7EDI | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation | |
7KEA | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification) | Spike glycoprotein |
7L58 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 | Spike glycoprotein, Fab H4 variable domain heavy chain, Fab H4 variable domain light chain |
7L7D | P0DTC2 | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895 | |
7LO4 | P0DTC2 | SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 | |
7LQ7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 | |
7LRS | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LS9 | P0DTC2 | Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7LWJ | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation | |
7LWP | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation | |
7LYL | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation | |
7LYM | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation | |
7M42 | P0DTC2 | Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989 | |
7MJN | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | Spike glycoprotein, Processed angiotensin-converting enzyme 2 |
7MLZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7E5S | P0DTC2 | SARS-CoV-2 S trimer with four-antibody cocktail complex | |
7NP1 | P0DTC2 | Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360 | |
7RR0 | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 222 | |
7SO9 | P0DTC2 | SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement | |
7SXS | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain | |
7SXU | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain | |
7V79 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 2 | |
7V7I | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2 | |
7MSQ | P0DTC2 | Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD) | |
7WBL | P0DTC2 | Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD | |
7WBP | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2 | |
7WBQ | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2 | |
7F7E | P0DTC2 | SARS-CoV-2 S protein RBD in complex with A5-10 Fab | |
7NLL | P0DTC2 | SARS-CoV-2 Spike RBD (dimer) in complex with two Fu2 nanobodies | |
7NS6 | P0DTC2 | SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies | |
7PQY | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FI-3A Fab | |
7PQZ | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FI-3A and FD-11A Fabs | |
7PR0 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FD-5D Fab | |
7SC1 | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8 | |
7TLY | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) | |
7TLZ | P0DTC2 | SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement | |
7TM0 | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
7TN0 | P0DTC2 | SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
7X1M | P0DTC2 | The complex structure of Omicron BA.1 RBD with BD604, S309,and S304 | |
7XAZ | P0DTC2 | Crystal structure of Omicron BA.1.1 RBD complexed with hACE2 | |
7XB0 | P0DTC2 | Crystal structure of Omicron BA.2 RBD complexed with hACE2 | |
7XB1 | P0DTC2 | Crystal structure of Omicron BA.3 RBD complexed with hACE2 | |
7Y42 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024